Cellular and morphological aspects of fibrodysplasia ossificans progressiva

References

• Raschke M, Kolbeck S, Bail H, Schmidmaier G, Flyvbjerg A, Lindner T, Dahne M, Roenne IA, Haas N. Homologous growth hormone accelerates healing of segmental bone defects. Bone 2001; 29:368-73; PMID:11595620; http://dx.doi.org/10.1016/S8756-3282(01)00587-7
   PubMed Web of Science ®Google Scholar
• Kneser U, Schaefer DJ, Polykandriotis E, Horch RE. Tissue engineering of bone: the reconstructive surgeon's point of view. J Cell Mol Med 2006; 10:7-19; PMID:16563218; http://dx.doi.org/10.1111/j.1582-4934.2006.tb00287.x
   PubMed Web of Science ®Google Scholar
• Zhang R, Gao Z, Geng W, Yan X, Chen F, Liu Y. Engineering vascularized bone graft with osteogenic and angiogenic lineage differentiated bone marrow mesenchymal stem cells. Artif Organs 2012; 36:1036-46; PMID:23020776; http://dx.doi.org/10.1111/j.1525-1594.2012.01529.x
   PubMedGoogle Scholar
• Fernández-Tresguerres-Hernández-Gil I, Alobera-Gracia MA, del-Canto-Pingarrón M, Blanco-Jerez L. Physiological bases of bone regeneration I. Histology and physiology of bone tissue. Med Oral Patol Oral Cir Bucal 2006; 11:E47-51; PMID:16388294
   PubMedGoogle Scholar
• Shapiro F. Bone development and its relation to fracture repair. The role of mesenchymal osteoblasts and surface osteoblasts. Eur Cell Mater 2008; 15:53-76; PMID:18382990
   PubMed Web of Science ®Google Scholar
• Magrini TD, Santos AR Jr., Rodrigues AA, Batista N, Belangero WD, Simas MP, Martinho HS. Analysis by FT-IR of three different bone regions: healthy, endochondral and intramembranous. Proc SPIE 2013; 8577:1
   Google Scholar
• Hench LL. Biomaterials: a forecast for the future. Biomaterials 1998; 19:1419-23; PMID:9794512; http://dx.doi.org/10.1016/S0142-9612(98)00133-1
   PubMed Web of Science ®Google Scholar
• Atala A. Engineering organs. Curr Opin Biotechnol 2009; 20:575-92; PMID:19896823; http://dx.doi.org/10.1016/j.copbio.2009.10.003
   PubMed Web of Science ®Google Scholar
• Santos AR Jr. Bioresorbable polymers for tissue engineering. In: Daniel Eberlin (Editor), Tissue engineering. Olajnica: In-Teh, 2010. p. 235-246
   Google Scholar
• Salter E, Goh B, Hung B, Hutton D, Ghone N, Grayson WL. Bone tissue engineering bioreactors: a role in the clinic? Tissue Eng Part B Rev 2012; 18:62-75; PMID:21902622; http://dx.doi.org/10.1089/ten.teb.2011.0209
   PubMedGoogle Scholar
• Lucchesi C, Ferreira BMP, Duek EAR, Santos AR Jr., Joazeiro PP. Increased response of Vero cells to PHBV matrices treated by plasma. J Mater Sci Mater Med 2008; 19:635-43; PMID:17619989; http://dx.doi.org/10.1007/s10856-007-0169-3
   PubMedGoogle Scholar
• Santos AR Jr., Wada MLF. Polímeros biorreabsorvíveis como arcabouços para cultura de células e engenharia tecidual. Polímeros Cien Tecnol 2007; 17:308-17
   Google Scholar
• Smith R, Athanasou NA, Vipond SE. Fibrodysplasia (myositis) ossificans progressiva: clinicopathological features and natural history. QJM 1996; 89:445-6; PMID:8758048; http://dx.doi.org/10.1093/qjmed/89.6.445
   PubMedGoogle Scholar
• Delai PLR, Kantanie S, Santili C, Kaplan FS. Fibrodisplasia ossificante progressiva: uma doença hereditária de interesse multidisciplinar. Rev Bras Ortop 2004; 39:205-13
   Google Scholar
• Romani F, Karam SM. Progressive ossifying fibrodysplasia: case report. Rev Bras Ortop 2011; 46:736-40; http://dx.doi.org/10.1590/S0102-36162011000600019
   Google Scholar
• Hsu JE. Current Review of Heterotopic Ossification. Uni Pennsyl Orthopaedic J 2010; 20:126-30
   Google Scholar
• Palhares DB, Leme LM. Miosite ossificante progressiva: uma perspectiva no controle da doença. J Pediatr 2001; 77:431-4
   Google Scholar
• Rothschild BM, Martin LD, Timm RM. A new spontaneous model of fibrodysplasia ossificans progressive. Brazi Geograph J Geosci Hum Res Medium 2010; 1:228-237
   Google Scholar
• Araújo CR Jr., Carvalho TN, Costa MAB, Lobo LV, Fonseca CR, Teixeira KS. Fibrodisplasia ossificante progressiva: relato de caso e achados radiográficos. Radiol Bras 2005; 38:69-73; http://dx.doi.org/10.1590/S0100-39842005000100014
   Google Scholar
• Campos DM, Renck DV, Bebber FE, Marquetto IB, Brum LF, Mendes L. Fibrodisplasia ossificante progressiva: relato de caso. Radiol Bras 2005; 38:393-5; http://dx.doi.org/10.1590/S0100-39842005000500017
   Google Scholar
• Kartal-Kaess M, Shore EM, Xu M, Schwering L, Uhl M, Korinthenberg R, Niemeyer C, Kaplan FS, Lauten M. Fibrodysplasia ossificans progressiva (FOP): watch the great toes! Eur J Pediatr 2010; 169:1417-21; PMID:20577760; http://dx.doi.org/10.1007/s00431-010-1232-5
   PubMedGoogle Scholar
• Shehab D, Elgazzar AH, Collier BD. Heterotopic ossification. J Nucl Med 2002; 43:346-53; PMID:11884494
   PubMed Web of Science ®Google Scholar
• Sferco A, Naser C, Robledo H, Fili T, Tramunt B. Fibrodysplasia osificante progresiva: pautas para su reconocimiento. Arch Argent Pediatr 2001; 99:249-52
   Google Scholar
• Kaplan FS, Pignolo RJ, Shore EM, et al. The seventeenth annual report of the fibrodysplasia ossificans progressiva (FOP) collaborative project. FOP Connection 2008;21:1-18, in http://www.tfrd.org.tw/english/news/upload/20080710027828_03.pdf.
   Google Scholar
• Lounev VY, Ramachandran R, Wosczyna MN, Yamamoto M, Maidment AD, Shore EM, Glaser DL, Goldhamer DJ, Kaplan FS. Identification of progenitor cells that contribute to heterotopic skeletogenesis. J Bone Joint Surg Am 2009; 91:652-63; PMID:19255227; http://dx.doi.org/10.2106/JBJS.H.01177
   PubMedGoogle Scholar
• Shaikh N, Arif F. Fibrodysplasia ossificans progressiva. J Pak Med Assoc 2011; 61:397-9; PMID:21465984
   PubMed Web of Science ®Google Scholar
• Pignolo RJ, Shore EM, Kaplan FS. Fibrodysplasia ossificans progressiva: clinical and genetic aspects. Orphanet J Rare Dis 2011; 6:80; PMID:22133093; http://dx.doi.org/10.1186/1750-1172-6-80
   PubMed Web of Science ®Google Scholar
• Gonçalves AL, Masruha MR, de Campos CC, Delai PLR, Vilanova LCP. Fibrodysplasia ossificans progressiva: case report. Arq Neuropsiquiatr 2005; 63:1090-3; PMID:16400434; http://dx.doi.org/10.1590/S0004-282×2005000600032
   PubMedGoogle Scholar
• Kaplan FS, Xu M, Glaser DL, Collins F, Connor M, Kitterman J, Sillence D, Zackai E, Ravitsky V, Zasloff M, et al. Early diagnosis of fibrodysplasia ossificans progressiva. Pediatrics 2008; 121:e1295-300; PMID:18450872; http://dx.doi.org/10.1542/peds.2007-1980
   PubMedGoogle Scholar
• Majmudar DK, Hathila NN, Vaishya KB. Sayani, Trivedi AV, Kalola JG. Fibrodysplasia ossificans progressiva. Ind J Radiol Imag 2005; 15:347-8; http://dx.doi.org/10.4103/0971-3026.29152
   Google Scholar
• Baysal T, Elmali N, Kutlu R, Baysal O. The stone man: myositis (fibrodysplasia) ossificans progressiva. Eur Radiol 1998; 8:479-81; PMID:9510591; http://dx.doi.org/10.1007/s003300050420
   PubMedGoogle Scholar
• Hammond P, Suttie M, Hennekam RC, Allanson J, Shore EM, Kaplan FS. The face signature of fibrodysplasia ossificans progressiva. Am J Med Genet A 2012; 158A:1368-80; PMID:22581580; http://dx.doi.org/10.1002/ajmg.a.35346
   PubMedGoogle Scholar
• Kitterman JA, Kantanie S, Rocke DM, Kaplan FS. Iatrogenic harm caused by diagnostic errors in fibrodysplasia ossificans progressiva. Pediatrics 2005; 116:e654-61; PMID:16230464; http://dx.doi.org/10.1542/peds.2005-0469
   PubMedGoogle Scholar
• Jackson WM, Aragon AB, Onodera J, Koehler SM, Ji Y, Bulken-Hoover JD, Vogler JA, Tuan RS, Nesti LJ. Cytokine expression in muscle following traumatic injury. J Orthop Res 2011; 29:1613-20; PMID:21452302; http://dx.doi.org/10.1002/jor.21354
   PubMedGoogle Scholar
• Nucci A, Queiroz LD, Santos AD, Camargo EE, Moura-Ribeiro MVL. Fibrodysplasia ossificans progressiva: case report. Arq Neuropsiquiatr 2000; 58(2A):342-7; PMID:10849638; http://dx.doi.org/10.1590/S0004-282x2000000200023
   PubMedGoogle Scholar
• Sendur OF, Gurer G. Severe limitation in jaw movement in a patient with fibrodysplasia ossificans progressiva: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 102:312-7; PMID:16920539; http://dx.doi.org/10.1016/j.tripleo.2005.09.020
   PubMedGoogle Scholar
• Tonholo-Silva ER, Adachi EA, Tafner MS, Yoshinaga L. Fibrodysplasia ossificans progressiva. Arq Neuropsiquiatr 1994; 52:100-2; PMID:8002796; http://dx.doi.org/10.1590/S0004-282x1994000100020
   PubMedGoogle Scholar
• Kaplan FS, Le Merrer M, Glaser DL, Pignolo RJ, Goldsby RE, Kitterman JA, Groppe J, Shore EM. Fibrodysplasia ossificans progressiva. Best Pract Res Clin Rheumatol 2008; 22:191-205; PMID:18328989; http://dx.doi.org/10.1016/j.berh.2007.11.007
   PubMed Web of Science ®Google Scholar
• Kaplan FS, Shore EM, Pignolo RJ, Glaser DL. Animal models of fibrodysplasia ossificans progressive. Clin Rev Bone Miner Metabolism 2005; 3:229-34; http://dx.doi.org/10.1385/BMM:3:3-4:229
   Google Scholar
• Yamaguchi A, Komori T, Suda T. Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr Rev 2000; 21:393-411; PMID:10950158; http://dx.doi.org/10.1210/edrv.21.4.0403
   PubMed Web of Science ®Google Scholar
• Moreira PL, An YH, Santos AR Jr., Genari SC. In vitro analysis of anionic collagen scaffolds for bone repair. J Biomed Mater Res B Appl Biomater 2004; 71:229-37; PMID:15386402; http://dx.doi.org/10.1002/jbm.b.30026
   PubMedGoogle Scholar
• da Luz Moreira P, Genari SC, Goissis G, Galembeck F, An YH, Santos AR Jr. Bovine osteoblasts cultured on polyanionic collagen scaffolds: an ultrastructural and immunocytochemical study. J Biomed Mater Res B Appl Biomater 2013; 101:18-27; PMID:22987821; http://dx.doi.org/10.1002/jbm.b.32804
   PubMedGoogle Scholar
• Xiao Y-T, Xiang L-X, Shao J-Z. Bone morphogenetic protein. Biochem Biophys Res Commun 2007; 362:550-3; PMID:17719560; http://dx.doi.org/10.1016/j.bbrc.2007.08.045
   PubMedGoogle Scholar
• Urist MR. Bone: formation by autoinduction. Science 1965; 150:893-9; PMID:5319761; http://dx.doi.org/10.1126/science.150.3698.893
   PubMed Web of Science ®Google Scholar
• Urist MR, Grant TT, Lindholm TS, Mirra JM, Hirano H, Finerman GA. Induction of new-bone formation in the host bed by human bone-tumor transplants in athymic nude mice. J Bone Joint Surg Am 1979; 61:1207-16; PMID:229105
   PubMed Web of Science ®Google Scholar
• Santos AA, Miranda CDO, Alves MTS, Faloppa F. The role of bone morphogenetic protein on bone tissue repair. Acta Ortop Bras 2005; 13:194-5
   Google Scholar
• Chen G, Deng C, Li YP. TGF-β and BMP signaling in osteoblast differentiation and bone formation. Int J Biol Sci 2012; 8:272-88; PMID:22298955; http://dx.doi.org/10.7150/ijbs.2929
   PubMed Web of Science ®Google Scholar
• Huang Z, Ren PG, Ma T, Smith RL, Goodman SB. Modulating osteogenesis of mesenchymal stem cells by modifying growth factor availability. Cytokine 2010; 51:305-10; PMID:20580248; http://dx.doi.org/10.1016/j.cyto.2010.06.002
   PubMedGoogle Scholar
• Gu K, Zhang L, Jin T, Rutherford RB. Identification of potential modifiers of Runx2/Cbfa1 activity in C2C12 cells in response to bone morphogenetic protein-7. Cells Tissues Organs 2004; 176:28-40; PMID:14745233; http://dx.doi.org/10.1159/000075025
   PubMedGoogle Scholar
• Carvalho DR, Navarro MMM, Martins BJAF, Coelho KEFA, Mello WD, Takata RI, Speck-Martins CE. Mutational screening of ACVR1 gene in Brazilian fibrodysplasia ossificans progressiva patients. Clin Genet 2010; 77:171-6; PMID:19796185; http://dx.doi.org/10.1111/j.1399-0004.2009.01256.x
   PubMed Web of Science ®Google Scholar
• Shore EM, Xu M, Feldman GJ, Fenstermacher DA, Cho TJ, Choi IH, Connor JM, Delai P, Glaser DL, LeMerrer M, et al. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet 2006; 38:525-7; PMID:16642017; http://dx.doi.org/10.1038/ng1783
   PubMed Web of Science ®Google Scholar
• Mattia S, Mantovani G, Guaral N, Pagano R, Venuta A, Ferrari P. Eteroplasia ossificante progressiva: una nuova mutazione del gene GNAS 1 e review della letteratura. Medico e Bambino 2008; 11
   Google Scholar
• Blaszczyk M, Majewski S, Brzezinska-Wcislo L, Jablonska S. Fibrodysplasia ossificans progressiva. Eur J Dermatol 2003; 13:234-7; PMID:12804980
   PubMed Web of Science ®Google Scholar
• Kaplan FS, Chakkalakal SA, Shore EM. Fibrodysplasia ossificans progressiva: mechanisms and models of skeletal metamorphosis. Dis Model Mech 2012; 5:756-62; PMID:23115204; http://dx.doi.org/10.1242/dmm.010280
   PubMed Web of Science ®Google Scholar
• Martelli A, Teixeira LBC, Santos AR Jr. Aspectos histopatológicos e histoquímico de osteossarcomas em cães. Estud Biol 2007; 29:179-89
   Google Scholar
• Crivelenti LZ, Borin S, Brum AM, Honsho DK. Fibrodysplasia ossificans progressiva-like in a cat. Arq Bras Med Vet Zootec 2012; 64:359-62;; http://dx.doi.org/10.1590/S0102-09352012000200015
   Google Scholar
• Kaplan FS, Groppe J, Pignolo RJ, Shore EM. Morphogen receptor genes and metamorphogenes: skeleton keys to metamorphosis. Ann N Y Acad Sci 2007; 1116:113-33; PMID:17872396; http://dx.doi.org/10.1196/annals.1402.039
   PubMedGoogle Scholar
• Ripamonti U, Reddi AH. Periodontal regeneration: potential role of bone morphogenetic proteins. J Periodontal Res 1994; 29:225-35; PMID:7932015; http://dx.doi.org/10.1111/j.1600-0765.1994.tb01216.x
   PubMed Web of Science ®Google Scholar
• Hughes FJ, Collyer J, Stanfield M, Goodman SA. The effects of bone morphogenetic protein-2, -4, and -6 on differentiation of rat osteoblast cells in vitro. Endocrinology 1995; 136:2671-7; PMID:7750491
   PubMed Web of Science ®Google Scholar
• Kaplan FS, Shen Q, Lounev V, Seemann P, Groppe J, Katagiri T, Pignolo RJ, Shore EM. Skeletal metamorphosis in fibrodysplasia ossificans progressiva (FOP). J Bone Miner Metab 2008; 26:521-30; PMID:18979151; http://dx.doi.org/10.1007/s00774-008-0879-8
   PubMedGoogle Scholar
• Kaplan FS, Fiori J, DE LA Peña LS, Ahn J, Billings PC, Shore EM. Dysregulation of the BMP-4 signaling pathway in fibrodysplasia ossificans progressiva. Ann N Y Acad Sci 2006; 1068:54-65; PMID:16831905; http://dx.doi.org/10.1196/annals.1346.008
   PubMed Web of Science ®Google Scholar
• van der Meij EH, Becking AG, van der Waal I. Fibrodysplasia ossificans progressiva. An unusual cause of restricted mandibular movement. Oral Dis 2006; 12:204-7; PMID:16476045; http://dx.doi.org/10.1111/j.1601-0825.2005.01171.x
   PubMedGoogle Scholar
• Shore EM, Kaplan FS. Insights from a rare genetic disorder of extra-skeletal bone formation, fibrodysplasia ossificans progressiva (FOP). Bone 2008; 43:427-33; PMID:18590993; http://dx.doi.org/10.1016/j.bone.2008.05.013
   PubMedGoogle Scholar
• Zhang D, Schwarz EM, Rosier RN, Zuscik MJ, Puzas JE, O’Keefe RJ. ALK2 functions as a BMP type I receptor and induces Indian hedgehog in chondrocytes during skeletal development. J Bone Miner Res 2003; 18:1593-604; PMID:12968668; http://dx.doi.org/10.1359/jbmr.2003.18.9.1593
   PubMed Web of Science ®Google Scholar
• Medici D, Shore EM, Lounev VY, Kaplan FS, Kalluri R, Olsen BR. Conversion of vascular endothelial cells into multipotent stem-like cells. Nat Med 2010; 16:1400-6; PMID:21102460; http://dx.doi.org/10.1038/nm.2252
   PubMed Web of Science ®Google Scholar
• Habibovic P, de Groot K. Osteoinductive biomaterials–properties and relevance in bone repair. J Tissue Eng Regen Med 2007; 1:25-32; PMID:18038389; http://dx.doi.org/10.1002/term.5
   PubMed Web of Science ®Google Scholar
• Lee SC, Shea M, Battle MA, Kozitza K, Ron E, Turek T, Schaub RG, Hayes WC. Healing of large segmental defects in rat femurs is aided by RhBMP-2 in PLGA matrix. J Biomed Mater Res 1994; 28:1149-56; PMID:7829545; http://dx.doi.org/10.1002/jbm.820281005
   PubMed Web of Science ®Google Scholar
• Whang K, Tsai DC, Nam EK, Aitken M, Sprague SM, Patel PK, Healy KE. Ectopic bone formation via rhBMP-2 delivery from porous bioabsorbable polymer scaffolds. J Biomed Mater Res 1998; 42:491-9; PMID:9827671; http://dx.doi.org/10.1002/(SICI)1097-4636(19981215)42:4≤491::AID-JBM3≥3.0.CO;2-F
   PubMed Web of Science ®Google Scholar
• Hollinger JO, Schmitt JM, Buck DC, Shannon R, Joh S-P, Zegzula HD, Wozney J. Recombinant human bone morphogenetic protein-2 and collagen for bone regeneration. J Biomed Mater Res 1998; 43:356-64; PMID:9855194; http://dx.doi.org/10.1002/(SICI)1097-4636(199824)43:4≤356::AID-JBM3≥3.0.CO;2-7
   PubMed Web of Science ®Google Scholar
• Zhang H, Ahmad M, Gronowicz G. Effects of transforming growth factor-beta 1 (TGF-beta1) on in vitro mineralization of human osteoblasts on implant materials. Biomaterials 2003; 24:2013-20; PMID:12628820; http://dx.doi.org/10.1016/S0142-9612(02)00616-6
   PubMedGoogle Scholar
• Ripamonti U, Ferretti C, Teare J, Blann L. Transforming growth factor-beta isoforms and the induction of bone formation: implications for reconstructive craniofacial surgery. J Craniofac Surg 2009; 20:1544-55; PMID:19816294; http://dx.doi.org/10.1097/SCS.0b013e3181b09ca6
   PubMedGoogle Scholar
• Schindeler A, Morse A, Peacock L, Mikulec K, Yu NYC, Liu R, Kijumnuayporn S, McDonald MM, Baldock PA, Ruys AJ, et al. Rapid cell culture and pre-clinical screening of a transforming growth factor-β (TGF-β) inhibitor for orthopaedics. BMC Musculoskelet Disord 2010; 11:105; PMID:20509926; http://dx.doi.org/10.1186/1471-2474-11-105
   PubMedGoogle Scholar
• Kaplan FS, Groppe J, Shore EM. When one skeleton is enough: approaches and strategies for the treatment of fibrodysplasia ossificans progressiva (FOP). Drug Discov Today Ther Strateg 2008; 5:255-62; PMID:23599718; http://dx.doi.org/10.1016/j.ddstr.2008.11.004
   PubMedGoogle Scholar
• Kaplan J, Kaplan FS, Shore EM. Restoration of normal BMP signaling levels and osteogenic differentiation in FOP mesenchymal progenitor cells by mutant allele-specific targeting. Gene Ther 2012; 19:786-90; PMID:22011642; http://dx.doi.org/10.1038/gt.2011.152
   PubMedGoogle Scholar